Effects of Aliskiren Monotherapy versus Amlodipine Monotherapy in Hypertensive Patients with Obesity or Type 2 Diabetes Mellitus
Introduction: Renin-angiotensin system inhibitors have been reported to exert protective effects against organ damage and failure; however, the impact of the direct renin inhibitor as monotherapy has not been assessed. Here, we investigated the effects of 24-week monotherapy with aliskiren compared...
Main Authors: | Yasufumi Seki, Satoshi Morimoto, Shihori Kimura, Noriyoshi Takano, Kaoru Yamashita, Kanako Bokuda, Nobukazu Sasaki, Daisuke Watanabe, Atsuhiro Ichihara |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2023-10-01
|
Series: | Kidney & Blood Pressure Research |
Subjects: | |
Online Access: | https://beta.karger.com/Article/FullText/533834 |
Similar Items
-
Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves' disease.
by: Yuki Mizuguchi, et al.
Published: (2018-01-01) -
CLINICAL EFFECTS AND RENOPROTECTIVE FACILITIES OF OLMESARTAN AND LERKANIDIPINEAS MONOTHERAPY AND WHEN COMBINED APPLICATION IN PATIENTS WITH ARTERIAL HYPERTENSION
by: A G Evdokimova, et al.
Published: (2016-03-01) -
Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
by: Kalathil K Sureshkumar
Published: (2008-12-01) -
Aliskiren: An orally active renin inhibitor
by: Pranay Wal, et al.
Published: (2011-01-01) -
ALISKIREN (RENIN INHIBITOR) AS THE RECENT ANTIHYPERTENSIVE MODALITY
by: Luh Gde Primahatini Suaka Putri
Published: (2013-12-01)